Joanne Beck

Insider Reports History

Location
C/O Catabasis Pharmaceuticals, Inc., One Kendall Sq, Bld. 1400 E, Suite B14202, Cambridge, MA
Signature
/s/ Ben Harshbarger, as attorney-in-fact for Joanne Beck
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joanne Beck:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Astria Therapeutics, Inc. Director Stock Option (Right to Buy) 26.6K Jun 11, 2025 Direct
Orchard Therapeutics plc Director Ordinary Shares 0 $0.46 Jan 24, 2024 Direct
Orchard Therapeutics plc Director Stock Option (Right to Buy) 0 Jan 24, 2024 Direct

Insider Reports Filed by Joanne Beck

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ATXS Astria Therapeutics, Inc. Jun 11, 2025 1 $0 4 Jun 12, 2025 Director
ATXS Astria Therapeutics, Inc. Jun 5, 2024 1 $0 4 Jun 6, 2024 Director
ORTX Orchard Therapeutics plc Jan 24, 2024 3 $0 4 Jan 24, 2024 Director
ORTX Orchard Therapeutics plc Jun 14, 2023 1 $0 4 Jun 16, 2023 Director
ATXS Astria Therapeutics, Inc. Jun 2, 2023 1 $0 4 Jun 6, 2023 Director
ATXS Astria Therapeutics, Inc. Jun 9, 2022 1 $0 4/A Jun 21, 2022 Director
ORTX Orchard Therapeutics plc Jun 7, 2022 1 $0 4 Jun 8, 2022 Director
ORTX Orchard Therapeutics plc Jun 16, 2021 1 $0 4 Jun 17, 2021 Director
ATXS CATABASIS PHARMACEUTICALS INC Jun 2, 2021 1 $0 4 Jun 2, 2021 Director